Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov;33(11):1464-1474.
doi: 10.1080/09540121.2020.1808160. Epub 2020 Aug 18.

Diabetes mellitus control in a large cohort of people with HIV in care-Washington, D.C

David E Wallace  1 , Michael A Horberg  2 , Debra A Benator  3   4 , Alan E Greenberg  1 , Amanda D Castel  1 , Anne K Monroe  1 , Lindsey Powers Happ  1 ; DC Cohort Executive Committee  1
Affiliations

Diabetes mellitus control in a large cohort of people with HIV in care-Washington, D.C

David E Wallace et al. AIDS Care. 2021 Nov.

Abstract

With more effective antiretroviral therapy (ART), people with HIV (PWH) are living longer and have more chronic diseases, including diabetes mellitus (DM). The prevalence of DM has been estimated in PWH previously, however there is less research regarding DM control. Our objectives were to determine the prevalence of DM and DM control and determine factors associated with DM control in a large urban cohort of PWH in care. We examined DC Cohort participants aged ≥18 years old to determine DM prevalence and to assess DM control (HbA1c measurement <7.0%). Demographic, clinical, and HIV-related factors associated with DM control were identified using multivariate logistic regression. The cohort of 5876 participants was predominantly male (71.3%), Non-Hispanic Black (78.1%) and had a median age of 52.0 years. DM prevalence was 17.4% (1023/5876). Among participants with recent HbA1c data available (39.9%) the proportion with DM control was 60.0% (245/408). In multivariate analysis, higher BMI (aOR: 0.47; 95% CI 0.28, 0.79) and use of non-insulin DM medication (aOR 0.43, 95% CI 0.25, 0.73) or insulin (aOR 0.010, 95% CI 0.04,0.24) compared to no medication use. Our findings suggest that individuals on medication for their DM likely need enhanced support to reach their treatment goals.

Keywords: Diabetes; Hemoglobin A1c; comorbidities; metabolic.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest:

For all authors, no conflicts of interest were declared.

References

    1. Aberg JA, Gallant JE, Ghanem KG, Emmanuel P, Zingman BS, & Horberg MA (2014). Primary Care Guidelines for the Management of Persons Infected With HIV: 2013 Update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis, 58(1), e1–e34. 10.1093/cid/cit665 - DOI - PubMed
    1. Aberg JA, Tebas P, Overton ET, Gupta SK, Sax PE, Landay A, … De La Rosa G (2012). Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks. AIDS Res Hum Retroviruses, 28(10), 1184–1195. 10.1089/aid.2011.0327 - DOI - PMC - PubMed
    1. Adeyemi O (2007). Cardiovascular risk and risk management in HIV-infected patients. Top HIV Med, 15(5), 159–162. - PubMed
    1. Adeyemi O, Vibhakar S, & Max B (2009). Are we meeting the American Diabetes Association goals for HIV-infected patients with diabetes mellitus? Clin Infect Dis, 49(5), 799–802. 10.1086/605286 - DOI - PubMed
    1. Armah KA, McGinnis K, Baker J, Gibert C, Butt AA, Bryant KJ, … Freiberg M (2012). HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. Clin Infect Dis, 55(1), 126–136. 10.1093/cid/cis406 - DOI - PMC - PubMed

Publication types